Ryan Specialty Earnings Call: Growth Strong, Margins Pinched

Ryan Specialty Group Holdings, Inc. Class A ((RYAN)) has held its Q4 earnings call. Read on for the main highlights of the call.

Ryan Specialty Group Holdings, Inc. struck a cautiously optimistic tone on its latest earnings call. Management highlighted robust full-year revenue and profit growth, accelerated expansion in delegated authority and products, and a steady M&A engine, yet warned that falling property prices, margin pressure, and restructuring costs will weigh on near-term performance even as long-term conviction remains high.

Strong Top-Line Momentum and Organic Growth

Ryan Specialty reported more than $3.0 billion in revenue for FY2025, up 21% year over year as M&A and organic expansion both contributed. Organic growth reached 10.1% for the full year and marked the company’s 15th straight year of double-digit growth, though Q4 slowed to 6.6%, hinting at a softer near-term rhythm.

Profitability Gains but Emerging Margin Pressure

Adjusted EBITDAC climbed 19.2% to $967 million in FY2025 and adjusted EPS rose 9.5% to $1.96, with Q4 adjusted EBITDAC of $222 million up 2.9%. Despite those gains, the adjusted EBITDAC margin slipped to 31.7% for the year and 29.6% in Q4 as business mix shifts and ongoing investments started to compress profitability.

Delegated Authority Now a Core Growth Engine

Delegated authority has become a central pillar of the model, with revenue doubling in two years to $1.4 billion and now accounting for 47% of total revenue versus 35% previously. The platform manages over $10 billion of premium across more than 300 products, deepening relationships with carriers and offering a scalable, fee-rich revenue stream.

Active M&A Strategy Expands Scale and Capabilities

The company closed five acquisitions in 2025 with trailing revenue above $125 million, extending its specialty footprint. Over the last two years, Ryan Specialty deployed nearly $2.7 billion across 12 deals, adding platforms such as Velocity, USQ, and 360 Underwriting to broaden products, geographies, and underwriting capabilities.

Disciplined Capital Allocation and Cash Generation

Strong free cash flow continues to underpin capital deployment, allowing management to balance growth investments and shareholder returns. The board authorized a $300 million share repurchase program and lifted the quarterly dividend by 8% to $0.13 per share, signaling confidence despite a tougher operating backdrop.

Broader International Reach and Product Diversification

Ryan Specialty has rapidly expanded its international presence, growing from six offices in 2023 to 24 today and widening its product shelf to more than 300 offerings. Several product lines have increased by roughly 50%, improving geographic balance and expanding the company’s addressable market across multiple specialty niches.

Strategic Reinsurance and Alternative Capital Initiatives

Through Ryan Re, the company deepened key partnerships, including its sidecar structure, and enhanced reinsurance capabilities to stabilize earnings across insurance cycles. It also launched in-house alternative capital management and benefits capabilities, aiming to diversify income streams beyond traditional property and casualty swings.

Sharp Property Pricing Declines Create a Near-Term Drag

Property pricing deteriorated notably in the fourth quarter, with certain larger accounts seeing rate cuts of 25% to 35% in December. Management expects similar softness to persist into 2026, which will likely pressure growth in property-related lines and contribute to more uneven quarterly performance.

Margin Compression Reflects Investments and Business Mix

The modest decline in FY2025 margins was tied to deliberate investments in talent and technology as well as mix shifts from high-margin areas. Q4 margins were particularly affected, reinforcing that the company is choosing to absorb near-term pressure in order to support long-term scaling and operational efficiency.

Guided Margin Headwinds From Income, Costs, and Investments

For 2026, Ryan Specialty expects organic growth to slow to the high-single-digit range while adjusted EBITDAC margins remain flat to slightly down. Lower fiduciary investment income, normalized contingent commissions, rising healthcare and benefits costs, and continued spending on talent and technology are all expected to weigh on profitability.

Restructuring Costs Now, Efficiency Gains Later

Project Empower will carry a cumulative special charge of about $160 million through 2028 as the company restructures to streamline operations. The initiative is designed to deliver around $80 million in annual run-rate savings beginning in 2029, implying that the financial benefits will be backloaded even as charges depress near-term results.

Construction and Builders Risk Exposed to Rate Environment

The builders risk managing general underwriter and certain large construction-related programs saw pressure from delayed or slower-moving projects. Higher interest rates and more challenging financing conditions stretched timelines, making these revenue streams lumpy and more difficult to forecast in the short term.

Contingent Commissions Likely to Normalize

The company benefited in 2025 from elevated contingent and profit commissions following relatively benign catastrophe activity. Management cautioned that these payments should be more stable but not repeat the exceptional levels seen last year, removing a tailwind that had supported margins.

Higher Interest Expense to Weigh on GAAP Results

With leverage at 3.2 times net, the company expects GAAP interest expense net of interest income to be about $210 million in 2026, including roughly $55 million in the first quarter. This higher funding cost will mute GAAP earnings growth even as the underlying specialty platform continues to expand.

Moderating Growth Amid Market Uncertainty

Management acknowledged that the operating backdrop is more challenging, pointing to property softness, moderating casualty trends, and macro uncertainty. As a result, they signaled that organic growth will likely step down from its historic double-digit pace and show more quarter-to-quarter variability in the near term.

Forward-Looking Guidance and Strategic Priorities

Ryan Specialty’s 2026 outlook centers on high-single-digit organic revenue growth, with the first quarter expected to be the strongest, and adjusted EBITDAC margins flat to slightly lower versus 2025. The company plans to absorb restructuring and investment headwinds while pursuing Project Empower savings by 2029, managing net interest costs, maintaining an approximate 26% adjusted tax rate, and returning capital via buybacks and dividend growth.

Ryan Specialty’s earnings call painted a company still growing quickly and investing aggressively, yet increasingly contending with cyclical and cost headwinds. For investors, the story is one of solid top-line momentum and strategic diversification balanced against near-term margin compression and a tempered growth outlook, with long-term value creation hinging on execution of M&A, reinsurance, and efficiency initiatives.